Project Number 1R21AG065657-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Development of Novel ERRa Selective Agonists as Chemical Probes for the Potential Treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) l. Growth Factors and Hormones Researcher and Organization Principal Investigator ELGENDY, BAHAA ELDIEN Principal Investigator First Name BAHAA ELDIEN Principal Investigator Last Name ELGENDY Awardee Organization ST. LOUIS COLLEGE OF PHARMACY Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR19-146: Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) FY Overall Cost $426,553 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
